Status:
COMPLETED
BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Norwegian Telemedicine
Kopera Norway
Conditions:
Cardiac Arrest, Out-Of-Hospital
Hypotension and Shock
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In a out of hospital emergency medicine study the investigators will measure hemodynamic effects of implemented treatments for patients with cardiac arrest, hypotension, and intensive care transports....
Detailed Description
Pre-hospital monitoring of vital signs has documented to increase survival. Especially advanced multi-monitoring units have shown to have this impact but they are demanding in use. Low blood pressure/...
Eligibility Criteria
Inclusion
- Non-traumatic cardiac arrest, hypotension, intensive care transport where an attempt of resuscitation and treatment is considered appropriate in patients age ≥18 years.
Exclusion
- Age \<18 years.
- Traumatic cardiac arrest
- Known pregnancy (can be included in the hypotension group)
- Victim not to be resuscitated (DNR orders)
- Internals in prison
- Included once in the study already
- Patients too small for LUCAS 2-AD2 \< 18.5 cm chest height
- Patient too big for LUCAS 2-AD2 \> 27.3 cm chest height
- Chest or upper abdomen surgery (Large scars on the chest, only in the CPR group.
- Sustained Restoration Of Spontaneous Circulation (ROSC) occurring before the LUCAS 2-AD2 can be applied to the patient, such that further CPR is not needed
Key Trial Info
Start Date :
May 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2024
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT04891380
Start Date
May 18 2021
End Date
January 3 2024
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Please Select, Norway, 0367